Risk factors for perinatal deaths in Pakistan

Fouzia Perveen1, Subhana Tayyab, Bader Faiyaz Zuberi

  • 1Dow University of Health Sciences, Karachi, Pakistan. perveen89rzw@yahoo.com

Insights

Risk factors for perinatal deaths in Pakistan, including low birthweight and abruptio placentae, were identified. Improved prenatal and intranatal care are crucial to reduce high perinatal mortality rates.

Area of Science:

  • Obstetrics and Gynecology
  • Perinatal Medicine
  • Public Health

Background:

  • Pakistan faces a high perinatal mortality rate, necessitating identification of associated risk factors.
  • Understanding these factors is crucial for developing targeted interventions and improving maternal and infant outcomes.

Purpose of the Study:

  • To identify significant risk factors contributing to perinatal deaths in Pakistan.
  • To analyze the association between demographic, obstetric, and fetal factors and perinatal mortality.

Main Methods:

  • A prospective cohort study was conducted in Karachi, Pakistan, enrolling 1103 deliveries.
  • Data collected included demographic information, birthweight, booking status, obstetric risk factors, and causes of death.
  • Univariate logistic regression analyzed the impact of various factors on perinatal death.

Main Results:

  • 119 perinatal deaths occurred, with stillbirths comprising 68.9% and early neonatal deaths 31.1%.
  • Significant risk factors included booking status, gestational age, fetal weight, and obstetric complications like abruptio placentae (13.4%).
  • Birth asphyxia was the leading cause of death (44.5%), with a strong association between birthweight and perinatal death.

Conclusions:

  • The study highlights poor health status, inadequate prenatal/intranatal care, and service deficiencies as contributors to high perinatal death rates.
  • Improving the quality of care, identifying high-risk cases, and ensuring proper management are essential to achieve Millennium Development Goals-4.
Abstract

Related Concept Videos

Development of the Oral Microbiota01:28

Development of the Oral Microbiota

The establishment of the oral microbiome begins before birth, challenging the long-held belief that the fetal oral cavity is sterile. The presence of oral microbes such as Streptococcus and Fusobacterium in amniotic fluid suggests that microbial exposure may occur in utero, potentially through translocation from the maternal oral or gastrointestinal tract. This early colonization primes the neonatal immune system and sets the stage for subsequent microbial succession. Maternal health,...
Drug Toxicity: Risk factors01:24

Drug Toxicity: Risk factors

Adverse Drug Reactions (ADRs) are potential complications that arise during pharmacotherapy, influenced by multiple risk factors. Age plays a significant role; both neonates and the elderly are at heightened risk due to their respective immature and diminished metabolic and elimination processes. Gender also impacts ADRs, with females experiencing a 1.5 to 1.7-fold greater risk than males, which may be linked to pharmacokinetic, pharmacodynamic, and hormonal differences. Notably, neonates, the...
Teratogenicity01:07

Teratogenicity

The ability of a drug to produce structural deformations and functional abnormalities in the developing embryo or the fetus is called teratogenicity, and the drug producing this effect is known as a teratogen. Teratogenic effects include stillbirth, miscarriage, intrauterine growth restriction, and neurocognitive delay. A teratogen may affect the embryo at different stages of development, which is important in determining the type and extent of the damage. During blastocyst formation, the early...
Pathophysiology of Diabetes01:20

Pathophysiology of Diabetes

Diabetes mellitus is a chronic metabolic disorder characterized by hyperglycemia. The four categories of diabetes are type 1 diabetes, type 2 diabetes, other specific types of diabetes, and gestational diabetes.
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility, suggesting a...
Pharmacokinetics in Pediatric Patients: Drug Distribution01:17

Pharmacokinetics in Pediatric Patients: Drug Distribution

Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight, compared...